drugset / Trial / NCT00396747

A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study

NCT00396747

Phase 4 Completed 45 enrolled Catholic University of Louvain
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to compare the effects of methotrexate (MTX) alone or in combination with intravenous (IV) methylprednisolone (MP) or infliximab (IFX) on MRI-detected synovitis, bone edema and erosive changes in early rheumatoid arthritis (RA) patients.

Timeline

Start
2003-06
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Infliximab Monoclonal antibody
Comparator Methotrexate Small molecule
Comparator Methylprednisolone Other / unclassified Intravenous

Indications